About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Post COVID-19 Condition | Clinical Trials | Clareo Health

RECRUITING

Post COVID-19 Condition

Assessment of Post COVID-19 Manifestations in a Multicenter Cohort Study (EuCARE-POSTCOVID Study)

NCT05531773•Euresist Network GEIE

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

COVID-19

Interventions

follow up of COVID-19 Patients

Locations

7

Germany

Locations (7)

University Hospital Heinrich Heine

Düsseldorf, Germany

Policlinico "Tor Vergata", Università degli Studi di Roma TOR VERGATA

Rome, Lazio, Italy

ASST Santi Paolo e Carlo

Milan, Lombardy, Italy

Vilnius University Hospital, Santaros Klinikos

Vilnius, Lithuania

Regional Hospital Dr. Juan Graham Casasús

Villahermosa, Tabasco, Mexico

Centro Hospitalar de Lisboa Ocidental

Lisbon, Portugal

Key Dates

Start Date

July 1, 2022

Primary Completion Date

December 15, 2025

Completion Date

December 15, 2025

Last Updated

September 19, 2025

Related Studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

RECRUITINGPhase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213

Adenovirus InfectionBK Virus Infection+5 more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665

COVID-19 InfectionCOVID-19-Associated Acute Respiratory Distress Syndrome+3 more

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT06871293

Long COVID-19 SyndromeCOVID 19+4 more

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

NCT04978571

Post-Concussion SyndromeCOVID Long-Haul+1 more

RECRUITINGPhase 1

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT07221162

View all related studies

Contacts

FRANCESCA INCARDONA, DR

CONTACT

+393356112830 francesca.incardona@euresist.org

ANTONELLA D'ARMINIO MONFORTE, PROF

CONTACT

+390281843045 antonella.darminio@unimi.it

Sponsors

Lead Sponsor

Euresist Network GEIE

Collaborators

ASST Santi Paolo e Carlo
Vilnius University Hospital Santaros Klinikos
Heinrich-Heine University, Duesseldorf
University of Rome Tor Vergata
Hospital Regional de Alta Especialidad "Dr. Juan Graham Casasus"
St Mary's Hospital, London
Centro Hospitalar Lisboa Ocidental

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions